Table 2.
All children | Preschool children () | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indicator | RR | 95% CI | (%) | RR | 95% CI | (%) | RR | 95% CI | (%) | ||||||
Traffic density | |||||||||||||||
All leukemia | 16 | 1.09 | 1.00, 1.20 | 56.2 | 0.012 | 7 | 1.00 | 0.93, 1.09 | 67.0 | 0.006 | 3 | 1.05 | 0.96, 1.15 | 10.0 | 0.002 |
Subtype | |||||||||||||||
ALL | 9 | 1.05 | 0.96, 1.16 | 34.7 | 0.005 | 3 | 1.02 | 0.99, 1.05 | 0.0 | 0.000 | 1 | 1.00 | 0.92, 1.09 | — | 0.000 |
AML | 5 | 1.09 | 0.86, 1.38 | 70.0 | 0.034 | 2 | 1.03 | 0.77, 1.38 | 87.7 | 0.039 | 1 | 1.25 | 1.02, 1.53 | — | 0.000 |
Exposure timing | |||||||||||||||
At birth | 5 | 0.98 | 0.90, 1.06 | 30.9 | 0.003 | 4 | 0.95 | 0.85, 1.05 | 52.4 | 0.006 | 1 | 1.15 | 0.78, 1.70 | — | 0.000 |
At diagnosis | 14 | 1.32 | 1.12, 1.55 | 50.7 | 0.033 | 3 | 1.27 | 0.95, 1.71 | 81.0 | 0.049 | 2 | 1.05 | 0.94, 1.17 | 24.6 | 0.004 |
Region | |||||||||||||||
Asia | 1 | 1.27 | 0.51, 3.17 | — | 0.000 | — | — | ||||||||
Europe | 9 | 1.25 | 1.05, 1.49 | 50.4 | 0.026 | 3 | 1.05 | 0.87, 1.25 | 63.8 | 0.017 | 1 | 1.05 | 0.95, 1.17 | — | 0.000 |
North America | 6 | 1.02 | 0.89, 1.16 | 65.4 | 0.014 | 4 | 0.98 | 0.84, 1.15 | 74.9 | 0.017 | 2 | 1.09 | 0.72, 1.64 | 17.4 | 0.032 |
Benzene | |||||||||||||||
All leukemia | 7 | 1.27 | 1.03, 1.56 | 52.4 | 0.043 | 4 | 1.39 | 1.03, 1.87 | 27.9 | 0.035 | 2 | 1.08 | 0.64, 1.82 | 0.0 | 0.000 |
Subtype | |||||||||||||||
ALL | 7 | 1.09 | 0.88, 1.36 | 51.8 | 0.034 | 3 | 1.19 | 1.00, 1.40 | 0.0 | 0.000 | 1 | 0.69 | 0.27, 1.78 | — | 0.000 |
AML | 5 | 1.84 | 1.31, 2.59 | 0.0 | 0.000 | 2 | 3.21 | 1.39, 7.42 | 0.0 | 0.000 | 1 | 0.43 | 0.04, 4.79 | — | 0.000 |
Exposure timing | |||||||||||||||
At birth | 3 | 1.21 | 1.04, 1.41 | 0.0 | 0.000 | 3 | 1.22 | 1.03, 1.43 | 0.0 | 0.000 | 1 | 1.14 | 0.63, 2.08 | — | 0.000 |
At diagnosis | 4 | 1.36 | 0.92, 2.00 | 65.2 | 0.125 | 1 | 3.30 | 1.03, 10.59 | — | 0.000 | 1 | 0.90 | 0.31, 2.60 | — | 0.000 |
Region | |||||||||||||||
Asia | — | — | — | ||||||||||||
Europe | 4 | 1.36 | 0.92, 2.00 | 65.2 | 0.125 | 1 | 3.30 | 1.03, 10.59 | — | 0.000 | 1 | 0.90 | 0.31, 2.60 | — | 0.000 |
North America | 3 | 1.21 | 1.04, 1.41 | 0.0 | 0.000 | 3 | 1.22 | 1.03, 1.43 | 0.0 | 0.000 | 1 | 1.14 | 0.63, 2.08 | — | 0.000 |
All leukemia | 8 | 1.04 | 0.90, 1.19 | 55.5 | 0.023 | 4 | 1.03 | 0.90, 1.18 | 14.9 | 0.004 | 1 | 0.89 | 0.42, 1.89 | — | 0.000 |
Subtype | |||||||||||||||
ALL | 4 | 1.02 | 0.89, 1.18 | 55.6 | 0.011 | 2 | 1.10 | 0.92, 1.32 | 46.2 | 0.008 | — | ||||
AML | 4 | 0.97 | 0.79, 1.19 | 0.0 | 0.000 | 2 | 0.86 | 0.60, 1.23 | 0.0 | 0.000 | — | ||||
Exposure timing | |||||||||||||||
At birth | 4 | 1.07 | 0.96, 1.19 | 0.0 | 0.000 | 4 | 1.03 | 0.90, 1.18 | 14.9 | 0.004 | 1 | 0.89 | 0.42, 1.89 | — | 0.000 |
At diagnosis | 4 | 1.17 | 0.82, 1.67 | 74.9 | 0.093 | — | — | ||||||||
Region | |||||||||||||||
Asia | 1 | 2.29 | 1.44, 3.64 | — | 0.000 | — | — | ||||||||
Europe | 4 | 0.91 | 0.82, 1.00 | 0.0 | 0.000 | 1 | 0.79 | 0.52, 1.20 | — | 0.000 | — | ||||
North America | 3 | 1.06 | 0.95, 1.18 | 0.0 | 0.000 | 3 | 1.06 | 0.94, 1.19 | 1.7 | 0.000 | 1 | 0.89 | 0.42, 1.89 | — | 0.000 |
Note: —, data not available; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CI, confidence interval; , I-squared statistic; RR, risk ratio; , tau-squared statistic.